Protective effects of the NAMPT activator P7C3-A20 on mouse neuronal injury in diabetic stroke: The role of intracellular NAMPT and SIRT1/FoxO3a signaling
Year: 2026
Type: article
Abstract: Diabetes is associated with a higher stroke risk, and outcomes are worse in patients with diabetes who experience strokes. Identifying diabetes-related factors may uncover mechanisms that exacerbate stroke in these patients. Nicotinamide phosphoribosyltransferase (NAMPT), an adipocytokine, is the rate-limiting enzyme for nicotinamide adenine dinucleotide + synthesis in the salvage pathway. NAMPT activation protects neurons; however, its roles in glucose metabolism disorders, cerebral ischemia, and cell death are unclear. Thus, we investigated NAMPT involvement in cerebral ischemic injury under diabetic conditions in type 2 diabetic (db/db) mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and in primary cultured cortical neurons. After MCAO/R, dimeric NAMPT protein levels decreased in the ischemic cortex of db/db mice and in primary cortical neurons exposed to high-glucose conditions (HGC) and oxygen–glucose deprivation/reoxygenation (OGDR), which mimic diabetic stroke conditions. HGC/OGDR increased extracellular dimeric NAMPT levels in cultured cortical neurons. Intracellular activation of NAMPT with P7C3-A20, a NAMPT activator, prevented HGC/OGDR-induced reductions in cell viability and intracellular dimeric NAMPT. Furthermore, elevated extracellular dimeric NAMPT was reduced after P7C3-A20 treatment. Intracellular NAMPT activation was associated with restored SIRT1 and FoxO3a levels. These findings demonstrate that diabetic stroke intensifies neuronal damage by disrupting the intracellular NAMPT/SIRT1/FoxO3a pathway and impairing FoxO3a activity. Therefore, intracellular dimeric NAMPT activation may support neuronal survival during diabetic stroke by modulating the SIRT1/FoxO3a pathway. • NAMPT activation protects neurons in diabetic stroke through SIRT1/FoxO3a signaling. • Diabetic conditions reduce intracellular dimeric NAMPT and SIRT1 in ischemic brain. • P7C3-A20 preserves dimeric NAMPT and improves cell survival under HGC/OGDR stress. • NAMPT loss increases cytoplasmic FoxO3a. • NAMPT–SIRT1–FoxO3a axis is a potential therapeutic target for diabetic stroke.
Source: Biomedicine & Pharmacotherapy
Institution: Tokyo University of Pharmacy and Life Sciences
Language: English
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,610
OpenAlex ID: W7118945650